Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

THIRD-PARTY INSPECTIONS COULD ELIMINATE SUBMISSION OF 510(k)s FOR SOME DESIGN CHANGES, FDA's JOHNSON SUGGESTS; "ONE-STOP SHOPPING" AUDITS POSSIBLE

This article was originally published in The Gray Sheet

Executive Summary

Third-party verification of manufacturers' compliance with FDA's quality systems regulation could eliminate the need for 510(k) clearance for at least some design changes, Ronald Johnson, director of FDA's Pacific Region office, said June 24 at a Food and Drug Law Institute meeting in Washington, D.C. Johnson made the suggestion as a possible incentive for industry to participate in a voluntary third-party inspection program.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008345

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel